Lyme disease vaccine

Cassandra Willyard December 16th, 2019 …”If the new vaccine does make it to market, will it fare any better than LYMErix? According to >Gregory Poland, co-director of the Vaccine Research Group at the Mayo Clinic in Rochester, Minnesota, who has given scientific advice to Valneva, that’s “a multi-million dollar question.” One factor that led to LYMErix’s demise…